Mesoblast (MESO) Accounts Payables (2015 - 2025)

Mesoblast (MESO) posted quarterly Accounts Payables of $33.6 million for Q4 2025, up 183.1% year-on-year from $11.9 million in Q4 2024, and up 75.96% on a QoQ basis from $19.1 million in Q2 2025.

Mesoblast (MESO) Accounts Payables (2015 - 2025) Analysis & Trends

Mesoblast (MESO) has reported Accounts Payables for 11 consecutive years, with $33.6 million the latest figure, recorded in Q4 2025.

  • Quarterly Accounts Payables rose 183.1% year-over-year to $33.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.6 million (up 183.1% YoY) and the FY2025 annual result came in at $19.1 million, up 169.9% from the prior year.
  • Accounts Payables improved to $33.6 million in Q4 2025 per MESO's latest filing, from $19.1 million in the prior quarter.
  • Over the last five years, Accounts Payables for MESO reached as high as $33.6 million in Q4 2025 and fell as low as $7.1 million in Q2 2024.
  • A 5-year average of $19.1 million and a median of $19.6 million in 2021 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2024 — Accounts Payables plunged 64.9% — and 2025, when it surged 183.1%.
  • Year by year, Accounts Payables stood at $20.9 million in 2021, then advanced by 9.91% to $23.0 million in 2022, then slumped by 53.2% to $10.8 million in 2023, then gained by 10.22% to $11.9 million in 2024, then jumped by 183.1% to $33.6 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods registered $33.6 million, $19.1 million, and $11.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Mesoblast 2.08 Bn 1.95 Bn - 33.58 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 33.58 Mn
Jun 30, 2025 19.08 Mn
Dec 31, 2024 11.86 Mn
Jun 30, 2024 7.07 Mn
Dec 31, 2023 10.76 Mn
Jun 30, 2023 20.15 Mn
Mar 31, 2023 20.97 Mn
Dec 31, 2022 22.99 Mn
Sep 30, 2022 17.66 Mn
Jun 30, 2022 23.08 Mn
Mar 31, 2022 18.98 Mn
Dec 31, 2021 20.92 Mn
Sep 30, 2021 16.26 Mn
Jun 30, 2021 19.60 Mn
Mar 31, 2021 24.28 Mn
Dec 31, 2020 28.61 Mn
Sep 30, 2020 27.60 Mn
Jun 30, 2020 24.97 Mn
Mar 31, 2020 19.48 Mn
Dec 31, 2019 19.24 Mn